Login
$DSS
$0.50 -$0.01 (1.2%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Inventory
Investments in trading securities
Assets held for sale
Current portion of notes receivable
Nonrelated Party
Related Party
Total current portion of notes receivable
Prepaid expenses and other current assets
Total current assets
Property, plant and equipment, net
Investment in real estate, net
Other investments
Investment, cost method
Investment, equity method
Investment in equity securities
Notes receivable
Nonrelated Party
Related Party
Total notes receivable
Convertible bond investment
Other assets
Right-of-use assets
Goodwill
Other intangible assets, net
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses and deferred revenue
Other current liabilities
Accrued interest on long-term debt
Current portion of lease liability
Current portion of long-term debt
Nonrelated Party
Related Party
Total current portion of long-term debt
Current portion of long-term debt on assets held-for-sale, net
Convertible note payable - related party, net
Total current liabilities
Long-term debt, net
Long term lease liability
Other long-term liabilities
Deferred tax liability, net
Total liabilities
Stockholders’ equity (deficit)
Common stock, $.02 par value; 200,000,000 shares authorized, 10,042,518 shares issued and outstanding on June 30, 2026 (9,092,518 on December 31, 2025)
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity of the Company
Non-controlling interest in subsidiaries
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support